Our twitter following grew quite dramatically in 2021. Over the last 12 months, we’ve grown from ~3,200 followers to ~4,550 followers! In this post, we celebrate some of our favorite tweets from 2021.

At Mammoth, we use twitter to share resources covering CRISPR, genome editing, diagnostics, infectious disease, diversity in STEM, Mammoth news, and more. Check out the summaries below to learn about some of the awesome things that happened at Mammoth in 2021!

Our successful series C/D raise accelerates the creation of the next generation of CRISPR products

Tweet: https://twitter.com/mammothbiosci/status/1435969521026691079

In September, we published a press release covering our highly successful series C/D fund raise. We’re using these funds to fuel the development of CRISPR-based therapies for serious genetic diseases, CRISPR diagnostics, and the continued growth of our dedicated team.

You can read the full press release here and apply for one of our many open positions here.

Our collaboration with Vertex Pharmaceuticals to develop in vivo gene-editing therapies for serious diseases

Tweet: https://twitter.com/mammothbiosci/status/1452986874302111754

Speaking of CRISPR-based therapies, in October we announced our collaboration with Vertex Pharmaceutics to develop in vivo gene-editing therapies for serious diseases. We’re incredibly excited to leverage the power of our ultra small Cas proteins, including those from the Cas14 and CasΦ families, to develop long-lasting cures for genetic diseases.

Read the press release covering our collaboration here and check out this interview with Mammoth CSO, Lucas Harrington, to learn more about our efforts in this area.

Mammoth CTO, Janice Chen, is recognized as an MIT Technology Review “Innovator Under 35”

Tweet: https://twitter.com/mammothbiosci/status/1410273301369298948

Our Co-Founders are rock stars. Indeed, Mammoth CTO Janice Chen was recognized as one of MIT Technology Review’s “Innovators Under 35” back in June. While completing her PhD in Mammoth Co-Founder and Nobel laureate, Jennifer Doudna’s Lab at UC Berkeley, Janice discovered that certain Cas proteins hold enormous potential for infectious disease diagnostics. Determined to make this potential a reality, Janice teamed up with Mammoth CSO Lucas Harrington, Mammoth CEO Trevor Martin, and Professor Doudna to found Mammoth right out of grad school. Janice and her fellow co-founders have deftly grown Mammoth into the groundbreaking company that it is today.

Learn more about Janice and her journey in this piece from the MIT Technology Review.

Celebrating International Day of Women in Science

Tweet: https://twitter.com/mammothbiosci/status/1359925533845299203

At Mammoth we strive to raise the voices of traditionally underrepresented scientists. Through the work of our Justice, Equity, Diversity, and Inclusion (JEDI) and Womxn and Allies at Mammoth committees, we organize projects and events that highlight the work of scientists from underrepresented backgrounds, make biotech a more welcoming place, and combat injustices. In this tweet from the 2021 International Day of Women in Science, we celebrated the fact that we are led by two astounding female Co-Founders, Janice Chen and Jennifer Doudna.

To learn more about projects from our JEDI and Womxn and Allies at Mammoth committees, check out this blog post and this blog post.

2021 was a difficult year for all of us, but we’re proud of all we accomplished. We look forward to making 2022 even better!